Rhumbline Advisers Has $20.23 Million Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

Rhumbline Advisers trimmed its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 737,912 shares of the real estate investment trust’s stock after selling 14,635 shares during the period. Rhumbline Advisers owned about 0.31% of Omega Healthcare Investors worth $20,226,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Resurgent Financial Advisors LLC acquired a new stake in Omega Healthcare Investors in the fourth quarter valued at $27,000. Nordwand Advisors LLC acquired a new stake in Omega Healthcare Investors during the 1st quarter worth about $27,000. GPS Wealth Strategies Group LLC acquired a new stake in Omega Healthcare Investors during the 1st quarter worth about $34,000. Aspire Private Capital LLC grew its holdings in Omega Healthcare Investors by 358.9% during the 4th quarter. Aspire Private Capital LLC now owns 1,317 shares of the real estate investment trust’s stock worth $36,796,622,000 after acquiring an additional 1,030 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in Omega Healthcare Investors by 1,331.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,660 shares of the real estate investment trust’s stock worth $46,000 after acquiring an additional 1,544 shares during the period. 65.50% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have weighed in on OHI shares. BMO Capital Markets started coverage on Omega Healthcare Investors in a report on Thursday, July 27th. They set a “market perform” rating and a $34.50 price target for the company. Stifel Nicolaus decreased their price target on Omega Healthcare Investors from $36.00 to $33.00 in a report on Wednesday, May 3rd. Berenberg Bank started coverage on Omega Healthcare Investors in a report on Thursday, July 27th. They set a “buy” rating for the company. Wells Fargo & Company increased their price target on Omega Healthcare Investors from $32.00 to $33.00 and gave the stock an “equal weight” rating in a report on Monday, August 7th. Finally, StockNews.com upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Friday, August 25th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $31.25.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI opened at $31.13 on Wednesday. Omega Healthcare Investors, Inc. has a fifty-two week low of $25.61 and a fifty-two week high of $33.16. The stock has a market cap of $7.62 billion, a price-to-earnings ratio of 30.52 and a beta of 1.00. The company has a debt-to-equity ratio of 1.39, a quick ratio of 5.55 and a current ratio of 5.55. The firm’s 50-day simple moving average is $31.30 and its 200 day simple moving average is $29.28.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Monday, July 31st were given a $0.67 dividend. The ex-dividend date was Friday, July 28th. This represents a $2.68 annualized dividend and a yield of 8.61%. Omega Healthcare Investors’s payout ratio is 262.75%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.